Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz
- Address
- Untere Zahlbacher Strasse 8, 55131 Mainz, Germany
Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz
The Klinik für Psychiatrie und Psychotherapie at Universitätsmedizin Mainz is a leading psychiatric research center specializing in optimizing treatment strategies for severe mental disorders. The center focuses on investigating early-intensified pharmacological interventions for patients experiencing first-line treatment failures, employing rigorous randomized controlled trial methodologies to advance evidence-based psychiatric care.
- Bipolar disorder management with focus on depressive episodes and treatment response optimization
- Schizophrenia spectrum disorders including schizoaffective and schizophreniform presentations
- Major depressive disorder treatment strategies following initial treatment failure
The center's research portfolio emphasizes comparative effectiveness studies between intensified pharmacological treatment protocols and treatment as usual approaches. Using standardized assessment tools such as the Montgomery Åsberg Depression Rating Scale (MADRS) and Positive And Negative Syndrome Scale (PANSS), researchers systematically evaluate symptom severity changes and treatment response outcomes across different psychiatric diagnoses, with particular attention to developing timely intervention strategies for patients who do not respond to first-line therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment. | Universitair Medisch Centrum Utrecht | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 34 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bupropion Hydrochloride | 2 | Unknown | 2025-02-11 | 2025-02-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.